|

adjuvant immunotherapy Clinical Trials

2 actively recruiting trials

Pipeline

Phase 3: 1

Top Sponsors

  • Sun Yat-sen University1
  • RenJi Hospital1

Indications

  • Cancer2
  • Muscle Invasive Upper Tract Urothelial Carcinoma1
  • De-escaltion Therapy1
  • Nasopharyngeal Carcinoma1

Other2 trials

Circulating and Urine Tumor DNA Dynamics Predict Minimal Residual Disease and Recurrence Risk in Locally Advanced Upper Tract Urothelial Carcinoma
Reduced-target Resection After Induction Chemotherapy in Resectable Recurrent Nasopharyngeal Carcinoma
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.